Proteonomix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://proteonomix.com
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Phase 1
- Conditions
- End Stage Liver DIsease
- Interventions
- Drug: Mobilization with G-CSF and Mozobil
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- Proteonomix, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01711073
- Locations
- 🇺🇸
University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath